Scarica l'app Stockscreener
276.08
0.10%
0.27
Pre-mercato:
277.33
1.25
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$275.81
Aprire:
$279.02
Volume 24 ore:
588.26K
Relative Volume:
1.11
Capitalizzazione di mercato:
$19.37B
Reddito:
$1.98B
Utile/perdita netta:
$420.90M
Rapporto P/E:
47.27
EPS:
5.84
Flusso di cassa netto:
$218.20M
1 W Prestazione:
+3.39%
1M Prestazione:
+3.57%
6M Prestazione:
+41.56%
1 anno Prestazione:
+35.03%
Intervallo 1D:
$275.87
$282.86
Intervallo di 1 settimana:
$263.13
$282.86
Portata 52W:
$160.19
$282.86
Insulet Corporation Stock (PODD) Company Profile
Nome
Insulet Corporation
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Confronta PODD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
276.08 | 19.37B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corporation Borsa (PODD) Ultime notizie
Diversify Wealth Management LLC Grows Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet (NASDAQ:PODD) Hits New 52-Week HighTime to Buy? - MarketBeat
Insulet stock hits 52-week high at $281.99 amid robust growth - Investing.com
Insulet Co. (NASDAQ:PODD) Shares Sold by AMI Asset Management Corp - MarketBeat
Sax Wealth Advisors LLC Acquires 1,532 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
6,742 Shares in Insulet Co. (NASDAQ:PODD) Purchased by Avanza Fonder AB - MarketBeat
(PODD) Investment Analysis - Stock Traders Daily
Assenagon Asset Management S.A. Has $27.25 Million Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
GEHC or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Contravisory Investment Management Inc. Takes $552,000 Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
USA Financial Formulas Makes New Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Purchased by Ayrshire Capital Management LLC - MarketBeat
Insulet rolls out Omnipod 5 in more European countries - Mass Device
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe - Business Wire
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Marketscreener.com
What Is Insulet Corporation's (NASDAQ:PODD) Share Price Doing? - Simply Wall St
Insulet Co. (NASDAQ:PODD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Insulet Stock Outperforming the Dow? - MSN
Insulet Sets Q4 2024 Earnings Date: Omnipod 5 Maker to Report Financial Results February 20 - StockTitan
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate? - Yahoo Finance
(PODD) On The My Stocks Page - Stock Traders Daily
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today - Benzinga
Insulet stock supported by Buy rating as analyst notes US type 2 label - Investing.com Canada
Insulet (NASDAQ:PODD) Price Target Raised to $324.00 - MarketBeat
Insulet Corporation (PODD) PT Raised to $324 at TD Cowen - StreetInsider.com
Those who invested in Insulet (NASDAQ:PODD) five years ago are up 49% - Simply Wall St
GEHC vs. PODD: Which Stock Is the Better Value Option? - Yahoo Finance
Insulet price target raised to $300 from $270 at BTIG - Yahoo Finance
Insulet Corporation (PODD) PT Raised to $300 at BTIG - StreetInsider.com
BTIG maintains Buy on Insulet stock, adjusting projections for Omnipod and EBIT margins - Investing.com Nigeria
Is Insulet Stock Outperforming The Dow? - Barchart
Heavy Interest in Insulet’s Insulin Delivery Device - Yahoo Finance
Principal Financial Group Inc. Grows Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
How to Take Advantage of moves in (PODD) - Stock Traders Daily
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Massachusetts Jury Sets New Record Under Federal Defend Trade Secrets Act With $452 Million Damages Award - JD Supra
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica - GlobeNewswire Inc.
The Most Significant Trade Secrets Cases Of 2024 - Law360
Executive VP Of Insulet Sold 26% Of Their Shares - Simply Wall St
Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St
Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India
Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia
Insulet Corporation Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):